These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20438317)

  • 1. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study.
    Salamina G; Diecidue R; Vigna-Taglianti F; Jarre P; Schifano P; Bargagli AM; Davoli M; Amato L; Perucci CA; Faggiano F;
    Subst Use Misuse; 2010 Oct; 45(12):2076-92. PubMed ID: 20438317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in Heroin Addiction and Treatment: Results from the VEdeTTE Cohort.
    Vigna-Taglianti FD; Burroni P; Mathis F; Versino E; Beccaria F; Rotelli M; Garneri M; Picciolini A; Bargagli AM;
    Subst Use Misuse; 2016; 51(3):295-309. PubMed ID: 26872763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
    Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors associated with retention in a community-based methadone maintenance treatment among heroin addicts].
    Hao C; Wu JL; Ruan YH; Yao HM; Yang XG; Liu L; Qin GM; Chen KL; Yin L; Song BL; Wang N; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jul; 41(4):250-3. PubMed ID: 17959041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.
    Bargagli AM; Faggiano F; Amato L; Salamina G; Davoli M; Mathis F; Cuomo L; Schifano P; Burroni P; Perucci CA;
    Subst Use Misuse; 2006; 41(14):1861-79. PubMed ID: 17162594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.
    Marsden J; Eastwood B; Bradbury C; Dale-Perera A; Farrell M; Hammond P; Knight J; Randhawa K; Wright C;
    Lancet; 2009 Oct; 374(9697):1262-70. PubMed ID: 19800681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors associated with retention in a community-based methadone maintenance treatment among drug users in Urumqi, Xinjiang Uigur Autonomous Region].
    Wang J; Li F; Mo LR; Li L; Guan YS; Hao C; Yin L; Li XX; Chen X; Ruan YH; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jan; 28(1):37-41. PubMed ID: 17575929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China.
    Li L; Sangthong R; Chongsuvivatwong V; McNeil E; Li J
    Drug Alcohol Depend; 2011 Jul; 116(1-3):246-9. PubMed ID: 21282020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China.].
    Cao XB; Yin WY; Pang L; Zhang CB; Xu JS; Xiao YK; Wang CH; Luo W; Zhang B; Zhang RM; Li ZJ; Rou KM; Wu ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):269-72. PubMed ID: 20510050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA; Resnick RB; Resnick E
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.